Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology
1 other identifier
observational
36
1 country
1
Brief Summary
This study included patients who underwent surgical treatment for incisional hernia and non-hernia conditions. Surgical specimens were collected for transcriptome sequencing to obtain the gene expression list. Then genes analyzed by Gene Ontology, protein interactions, and signaling pathway enrichment using the expression matrix.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
April 16, 2024
CompletedApril 16, 2024
March 1, 2024
6 months
March 7, 2024
April 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
the gene expression list
the gene expression list
2023.3-2023.9
Study Arms (2)
IH group
Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group)
NC group
patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group)
Interventions
Eligibility Criteria
Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group), and patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group).
You may qualify if:
- to 75 years 2.diagnosed with incisional hernia 3.normal tumour markers 4.elective surgery patients.
You may not qualify if:
- patients with vital organ failure (heart liver, lung, kidney and others)
- malignant tumors not been completely relieved by active treatment,
- patients who have psychiatric diseases or comprehension disorders.
- patients with metabolic disease involving connective tissue collagen.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Hua Dong Hospital Affiliated to Fu Dan University
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
March 7, 2024
First Posted
April 16, 2024
Study Start
March 1, 2023
Primary Completion
September 1, 2023
Study Completion
March 1, 2024
Last Updated
April 16, 2024
Record last verified: 2024-03